Anthocyanidin Reductase Assay Kit
Pack Size - 50T/24S Cost - 23730
Pack Size - 100T/48S Cost - 40530
Indoleacetic acid oxidase Assay Kit
Pack Size - 50T/24S Cost - 17430
Pack Size - 100T/48S Cost - 27930
Plant Anthocyanin Assay Kit
Pack Size - 50T/24S Cost - 15120
Genomic DNA kit (blood, cells, tissues etc) Bacteria DNA kit Marine DNA kit Plant Genomic DNA kit Blood DNA kit (0.1-1mL) Stool DNA kit Fungal DNA kit FFPE DNA kit Virus DNA / RNA kit
PCR Mini Purification Kit Gel Mini Purification K
100bp DNA Ladder 100bp Plus DNA Ladder 1kb DNA Ladder 1kb Plus DNA Ladder 50bp DNA Ladder 200bp DNA Ladder 500bp DNA Ladder
Miniprep Plasmid kit Yeast Plasmid DNA kit
The RPR test is a non-treponemal serological test used to detect antibodies produced in response to Treponema pallidum, the bacterium that causes syphilis. It's a qualitative test, meaning it gives a positive or negative result. The RPR test is typically performed on serum or plasma obtained from a blood sample. In the RPR test, the patient's serum or plasma is mixed with a solution containing cardiolipin, lecithin, and cholesterol particles. If the patient's serum contains antibodies against Treponema pallidum, these antibodies will react with the cardiolipin-lecithin-cholesterol particles, causing visible agglutination or clumping. The RPR card is a specialized card or slide designed to perform the RPR test. It typically contains multiple wells or spots where the serum/plasma sample and the reagent are mixed, allowing for easy observation of agglutination reactions. These cards are convenient for laboratory use, enabling multiple samples to be tested simultaneously and facilitating the interpretation of results.
The RPR test is a non-treponemal serological test used to detect antibodies produced in response to Treponema pallidum, the bacterium that causes syphilis. It's a qualitative test, meaning it gives a positive or negative result. The RPR test is typically performed on serum or plasma obtained from a blood sample. In the RPR test, the patient's serum or plasma is mixed with a solution containing cardiolipin, lecithin, and cholesterol particles. If the patient's serum contains antibodies against Treponema pallidum, these antibodies will react with the cardiolipin-lecithin-cholesterol particles, causing visible agglutination or clumping. A "RPR test slide" could refer to a specialized slide or card used to perform the RPR test. This slide likely contains wells or spots where the serum/plasma sample and the reagent are mixed, allowing for easy observation of agglutination reactions. These test slides are a convenient way to perform the RPR test in a laboratory setting, allowing for multiple samples to be tested simultaneously and facilitating the interpretation of results.
"Factview S. Typhus" may refer to a specific product or brand related to the diagnosis or management of typhus, but without more context, it's challenging to provide precise information. However, I can offer general information about typhus: Types of Typhus: Typhus is a group of infectious diseases caused by different species of bacteria from the genus Rickettsia. The two primary types of typhus that affect humans are epidemic typhus and endemic (murine) typhus. Epidemic Typhus: This type is caused by Rickettsia prowazekii and is transmitted to humans through the bites of infected body lice. Epidemic typhus occurs in outbreaks, often in overcrowded and unsanitary conditions. Endemic (Murine) Typhus: This type is caused by Rickettsia typhi and is transmitted to humans through the bites of infected fleas, typically from rats or other rodents. Endemic typhus is usually milder than epidemic typhus and occurs sporadically in various regions around the world. Symptoms: Symptoms of typhus can vary depending on the type and severity of the infection but often include high fever, headache, rash, muscle aches, and fatigue. Severe cases can lead to complications such as pneumonia, kidney failure, or even death if left untreated. Diagnosis: Diagnosis of typhus typically involves clinical evaluation, including symptoms and medical history, along with laboratory tests such as blood tests to detect antibodies against Rickettsia bacteria or molecular tests to detect the genetic material of the bacteria. Treatment: Typhus is treated with antibiotics, primarily tetracycline or doxycycline, which are effective against Rickettsia bacteria. Prompt treatment is essential to prevent complications and reduce the severity of the illness. Prevention: Preventive measures for typhus include avoiding contact with lice and fleas, practicing good personal hygiene, using insect repellent, and controlling rodent populations in areas where typhus is endemic.
"Factview H. pylori Ab" likely refers to a diagnostic test for detecting antibodies against Helicobacter pylori in biological samples. Helicobacter pylori is a bacterium that colonizes the stomach lining and is associated with various gastrointestinal conditions, including gastritis, peptic ulcers, and even stomach cancer. The "H. pylori Ab" test is designed to identify the presence of antibodies produced by the body in response to H. pylori infection. These antibodies can be detected in serum (blood) samples and serve as markers of past or present H. pylori infection. The test usually involves collecting a blood sample from the patient and then processing it to detect H. pylori antibodies using immunological methods such as enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA). These methods rely on the specific binding of antibodies to H. pylori antigens present in the test kit, leading to a visible or measurable signal indicating the presence of antibodies. Detection of H. pylori antibodies in clinical samples can help confirm H. pylori infection and guide appropriate treatment strategies. However, it's important to note that the presence of antibodies may indicate either current or past infection, as antibodies can persist in the bloodstream for some time after the infection has been cleared. Therefore, additional tests or clinical evaluation may be necessary to determine the timing and severity of the infection.
Factview H. pylori Ag" likely refers to a diagnostic test for detecting Helicobacter pylori antigens in biological samples. Helicobacter pylori is a bacterium that colonizes the stomach lining and is associated with various gastrointestinal conditions, including gastritis, peptic ulcers, and even stomach cancer. The "H. pylori Ag" test is designed to identify the presence of antigens produced by H. pylori in specimens such as stool, saliva, or gastric tissue. This test is valuable for diagnosing H. pylori infection, as it offers a non-invasive alternative to traditional methods such as endoscopy with biopsy. The test usually involves collecting a sample from the patient, typically stool, and then processing it to detect H. pylori antigens using immunological methods such as enzyme immunoassay (EIA) or lateral flow immunoassay. These methods rely on the specific binding of antibodies to H. pylori antigens present in the sample, leading to a visible or measurable signal indicating the presence of the bacterium. The detection of H. pylori antigens in clinical samples can aid in the diagnosis of H. pylori infection and help guide appropriate treatment strategies, such as antibiotic therapy and acid-suppressing medications. It is particularly useful for monitoring treatment effectiveness and detecting H. pylori recurrence after treatment completion.
"VTM" commonly stands for Viral Transport Medium. It's a solution used in the field of virology and microbiology to preserve and transport viral specimens collected from patients. VTM serves several crucial purposes: Preservation: VTM helps maintain the viability and integrity of viruses present in the specimen during transportation from the collection site to the laboratory. It prevents the degradation of viral particles, ensuring accurate testing and diagnosis. Inactivation: Some VTMs may contain agents that inactivate bacteria and fungi present in the specimen while preserving viruses. This prevents bacterial and fungal overgrowth, which could interfere with viral testing. Stabilization: VTM stabilizes the viral particles, preventing changes in their structure or characteristics that could occur during transportation or storage. This stability is essential for maintaining the accuracy of diagnostic tests. Facilitating Laboratory Processing: VTM is designed to be compatible with various laboratory testing methods, including viral culture, nucleic acid amplification (such as PCR), and antigen detection assays. It ensures that the specimen can be readily processed upon arrival at the laboratory. Safety: VTM may contain components that help reduce the risk of viral transmission during specimen handling and transportation, protecting laboratory personnel and others from potential exposure to infectious agents. VTM typically consists of a buffered saline solution supplemented with proteins, antibiotics, and antifungal agents to maintain the viability of viruses and prevent contamination. The composition may vary depending on the specific requirements of the viral specimens being transported and the testing methods used in the laboratory.
VDRL (Venereal Disease Research Laboratory) and RPR (Rapid Plasma Reagin) are both laboratory tests used for screening and diagnosing syphilis. VDRL (Venereal Disease Research Laboratory) Test: The VDRL test is a screening test for syphilis. It detects the presence of antibodies produced by the body in response to the bacterium Treponema pallidum, which causes syphilis. The test involves mixing the patient's blood serum with a substance that mimics syphilis antigens. If antibodies to syphilis are present, they will react with these antigens, causing visible clumping (agglutination) in the test tube. The VDRL test is often used as an initial screening test, but it may sometimes produce false-positive results or false-negative results, especially in early or late stages of syphilis. RPR (Rapid Plasma Reagin) Test: The RPR test is another screening test for syphilis that works on a similar principle to the VDRL test. It detects antibodies produced by the body in response to Treponema pallidum. Like the VDRL test, the RPR test involves mixing the patient's blood serum with a substance that contains antigens related to syphilis. If antibodies to syphilis are present, they will react with these antigens, causing visible clumping or agglutination. The RPR test is also used as an initial screening test, and it may produce false-positive or false-negative results in certain situations. Both the VDRL and RPR tests are commonly used for screening purposes, but they are usually followed up with more specific confirmatory tests, such as the Treponemal test (e.g., FTA-ABS or TP-PA), to confirm the diagnosis of syphilis. These confirmatory tests detect antibodies that specifically target Treponema pallidum, providing more accurate results.
VDRL (Venereal Disease Research Laboratory) is a test used to detect the presence of antibodies produced by the body in response to the bacterium Treponema pallidum, which causes syphilis. The VDRL test is a screening test for syphilis, and it's commonly performed on blood samples. The VDRL test typically involves mixing a patient's blood serum with a substance that mimics the antigens produced by the bacterium that causes syphilis. If antibodies to syphilis are present in the serum, they will react with these antigens, causing visible clumping (agglutination) in the test tube. The degree of clumping is then assessed visually or with the help of laboratory equipment. Strip tests for syphilis detection work on similar principles but are often designed for rapid and easy use. These strips contain specific antigens or antibodies that react with the patient's blood sample, producing a visible result that indicates the presence or absence of syphilis antibodies. The VDRL strip test, like other rapid diagnostic tests, offers quick results, making it valuable for screening purposes, especially in resource-limited settings or where timely diagnosis is critical. However, it's essential to confirm positive results with additional tests, as false positives can occur, especially in populations with low prevalence rates of syphilis.
